Celecoxib treatment was efficacious for the prevention of intact neu-induced rat mammary carcinomas, reducing tumor multiplicity in two independent trials by 56% (P < 0.0001, Table 1 and Figure 1a) and by 74% (P = 0.0003, Table 1 and Figure 1c). Here, ERBB2 is linked to breast carcinoma.